|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/2013 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3300483 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16818153.5 |
| Date of filing the European patent application | 2016-06-20 | |
| (97) | Date of publication of the European application | 2018-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2016/006513 |
| Date | 2016-06-20 |
| (87) | Number | WO 2017/003120 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 20150093413 | 2015-06-30 | KR |
| (72) |
PARK, Caleb Hyung Min , KR
JUNG, Myeong Ki , KR
KIM, Jin Cheul , KR
KIM, Yong Il , KR
PARK, Jae Hyun , KR
WOO, Jong Soo , KR
|
| (73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536,
KR
|
| (54) | ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME |
| ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME |